Value proposition

Transforming Healthcare, Backed by Over a Century of Expertise

Norgine is a uniquely positioned, specialty pharmaceutical and consumer healthcare company, with more than €500 million of annual revenues and a 120-year track record of bringing life-changing products to patients and consumers across their core markets of Western Europe, Australia, and New Zealand. Today’s Norgine is a nimble, innovative, and high-performing company that has been transformed by a relentless focus on operational excellence to do the right thing by patients, push boundaries, and take strides into new therapeutic areas. The company’s integrated approach – strong commercial capabilities, deep medical, regulatory and clinical expertise, in-house manufacturing, robust supply networks, and best-in-class enabling functions – ensures delivery of high-quality, transformative medicines quickly and effectively to more than 25 million patients annually.


Hepatology, Cancer and supportive care, Women's health , Colonoscopy, Partnering , Acquisition, Gastroenterology, In-licensing, Out-licensing, Hepatic Encephalopathy, and Paediatric Oncology